nodes	percent_of_prediction	percent_of_DWPC	metapath
Clozapine—ADRA1B—polycystic ovary syndrome	0.355	0.496	CbGaD
Clozapine—ADRA1A—polycystic ovary syndrome	0.239	0.334	CbGaD
Clozapine—CYP1A1—polycystic ovary syndrome	0.122	0.17	CbGaD
Clozapine—FMO3—urine—polycystic ovary syndrome	0.00496	0.0775	CbGeAlD
Clozapine—CYP2C19—urine—polycystic ovary syndrome	0.00219	0.0342	CbGeAlD
Clozapine—CALY—pituitary gland—polycystic ovary syndrome	0.00199	0.031	CbGeAlD
Clozapine—CYP1A2—urine—polycystic ovary syndrome	0.00179	0.028	CbGeAlD
Clozapine—CYP2C9—urine—polycystic ovary syndrome	0.0017	0.0265	CbGeAlD
Clozapine—CYP2E1—urine—polycystic ovary syndrome	0.00161	0.0251	CbGeAlD
Clozapine—CALY—endocrine gland—polycystic ovary syndrome	0.00154	0.0241	CbGeAlD
Clozapine—HTR2A—urine—polycystic ovary syndrome	0.0014	0.0219	CbGeAlD
Clozapine—FMO3—adrenal cortex—polycystic ovary syndrome	0.00131	0.0205	CbGeAlD
Clozapine—CYP3A4—urine—polycystic ovary syndrome	0.00129	0.0202	CbGeAlD
Clozapine—CYP2D6—urine—polycystic ovary syndrome	0.00127	0.0199	CbGeAlD
Clozapine—H1F0—embryo—polycystic ovary syndrome	0.00117	0.0184	CbGeAlD
Clozapine—UGT1A4—endocrine gland—polycystic ovary syndrome	0.00117	0.0182	CbGeAlD
Clozapine—HTR1E—female gonad—polycystic ovary syndrome	0.0011	0.0171	CbGeAlD
Clozapine—FMO3—pituitary gland—polycystic ovary syndrome	0.00106	0.0166	CbGeAlD
Clozapine—FMO3—adipose tissue—polycystic ovary syndrome	0.00106	0.0165	CbGeAlD
Clozapine—H1F0—adrenal cortex—polycystic ovary syndrome	0.000963	0.015	CbGeAlD
Clozapine—FMO3—adrenal gland—polycystic ovary syndrome	0.000948	0.0148	CbGeAlD
Clozapine—FMO3—vagina—polycystic ovary syndrome	0.000878	0.0137	CbGeAlD
Clozapine—H1F0—endometrium—polycystic ovary syndrome	0.00086	0.0134	CbGeAlD
Clozapine—FMO3—endocrine gland—polycystic ovary syndrome	0.000822	0.0128	CbGeAlD
Clozapine—H1F0—uterus—polycystic ovary syndrome	0.000792	0.0124	CbGeAlD
Clozapine—H1F0—pituitary gland—polycystic ovary syndrome	0.000778	0.0122	CbGeAlD
Clozapine—H1F0—adipose tissue—polycystic ovary syndrome	0.000775	0.0121	CbGeAlD
Clozapine—CYP2A6—adipose tissue—polycystic ovary syndrome	0.000726	0.0113	CbGeAlD
Clozapine—H1F0—adrenal gland—polycystic ovary syndrome	0.000695	0.0109	CbGeAlD
Clozapine—H1F0—female gonad—polycystic ovary syndrome	0.000648	0.0101	CbGeAlD
Clozapine—H1F0—vagina—polycystic ovary syndrome	0.000644	0.0101	CbGeAlD
Clozapine—Ziprasidone—ADRA1B—polycystic ovary syndrome	0.000621	0.119	CrCbGaD
Clozapine—CYP2A6—vagina—polycystic ovary syndrome	0.000603	0.00943	CbGeAlD
Clozapine—H1F0—endocrine gland—polycystic ovary syndrome	0.000603	0.00942	CbGeAlD
Clozapine—Azelastine—ADRA1B—polycystic ovary syndrome	0.000582	0.112	CrCbGaD
Clozapine—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000546	0.00853	CbGeAlD
Clozapine—CYP1B1—uterus—polycystic ovary syndrome	0.000544	0.0085	CbGeAlD
Clozapine—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000534	0.00835	CbGeAlD
Clozapine—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000532	0.00832	CbGeAlD
Clozapine—CHRM3—adipose tissue—polycystic ovary syndrome	0.000502	0.00785	CbGeAlD
Clozapine—Olanzapine—ADRA1B—polycystic ovary syndrome	0.0005	0.0962	CrCbGaD
Clozapine—ADRA2C—endometrium—polycystic ovary syndrome	0.000488	0.00762	CbGeAlD
Clozapine—HTR1B—endocrine gland—polycystic ovary syndrome	0.000482	0.00754	CbGeAlD
Clozapine—CHRM2—endocrine gland—polycystic ovary syndrome	0.00048	0.0075	CbGeAlD
Clozapine—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000477	0.00746	CbGeAlD
Clozapine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000461	0.00721	CbGeAlD
Clozapine—DRD2—pituitary gland—polycystic ovary syndrome	0.000454	0.00709	CbGeAlD
Clozapine—CYP2C8—endometrium—polycystic ovary syndrome	0.000452	0.00707	CbGeAlD
Clozapine—HTR2A—embryo—polycystic ovary syndrome	0.000452	0.00707	CbGeAlD
Clozapine—ADRA2C—uterus—polycystic ovary syndrome	0.000449	0.00702	CbGeAlD
Clozapine—HTR1A—adrenal gland—polycystic ovary syndrome	0.000449	0.00701	CbGeAlD
Clozapine—CYP1B1—female gonad—polycystic ovary syndrome	0.000445	0.00696	CbGeAlD
Clozapine—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000441	0.0069	CbGeAlD
Clozapine—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000439	0.00687	CbGeAlD
Clozapine—CHRM1—endocrine gland—polycystic ovary syndrome	0.000437	0.00682	CbGeAlD
Clozapine—HTR7—adrenal gland—polycystic ovary syndrome	0.000429	0.0067	CbGeAlD
Clozapine—CHRM3—female gonad—polycystic ovary syndrome	0.00042	0.00657	CbGeAlD
Clozapine—Ziprasidone—ADRA1A—polycystic ovary syndrome	0.000418	0.0804	CrCbGaD
Clozapine—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000414	0.00647	CbGeAlD
Clozapine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000414	0.00646	CbGeAlD
Clozapine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000409	0.00639	CbGeAlD
Clozapine—HRH1—endometrium—polycystic ovary syndrome	0.000396	0.00619	CbGeAlD
Clozapine—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000394	0.00616	CbGeAlD
Clozapine—CHRM3—endocrine gland—polycystic ovary syndrome	0.000391	0.00611	CbGeAlD
Clozapine—HTR1A—endocrine gland—polycystic ovary syndrome	0.000389	0.00608	CbGeAlD
Clozapine—ADRA2A—endometrium—polycystic ovary syndrome	0.000389	0.00608	CbGeAlD
Clozapine—CYP2C19—vagina—polycystic ovary syndrome	0.000388	0.00607	CbGeAlD
Clozapine—CYP1A1—uterus—polycystic ovary syndrome	0.000385	0.00601	CbGeAlD
Clozapine—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000376	0.00588	CbGeAlD
Clozapine—HTR7—endocrine gland—polycystic ovary syndrome	0.000372	0.00581	CbGeAlD
Clozapine—ADRA2C—female gonad—polycystic ovary syndrome	0.000368	0.00574	CbGeAlD
Clozapine—ADRA2C—vagina—polycystic ovary syndrome	0.000365	0.00571	CbGeAlD
Clozapine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000363	0.00568	CbGeAlD
Clozapine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000359	0.00561	CbGeAlD
Clozapine—ADRA2A—uterus—polycystic ovary syndrome	0.000359	0.0056	CbGeAlD
Clozapine—HRH1—adipose tissue—polycystic ovary syndrome	0.000357	0.00558	CbGeAlD
Clozapine—Quetiapine—ADRA1D—polycystic ovary syndrome	0.000355	0.0684	CrCbGaD
Clozapine—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.000353	0.068	CrCbGaD
Clozapine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000352	0.0055	CbGeAlD
Clozapine—DRD2—endocrine gland—polycystic ovary syndrome	0.000352	0.00549	CbGeAlD
Clozapine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000351	0.00548	CbGeAlD
Clozapine—CYP2C8—vagina—polycystic ovary syndrome	0.000339	0.00529	CbGeAlD
Clozapine—Olanzapine—ADRA1A—polycystic ovary syndrome	0.000336	0.0647	CrCbGaD
Clozapine—Trazodone—ADRA1A—polycystic ovary syndrome	0.000325	0.0626	CrCbGaD
Clozapine—HRH1—adrenal gland—polycystic ovary syndrome	0.00032	0.005	CbGeAlD
Clozapine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000317	0.00495	CbGeAlD
Clozapine—CYP1A1—female gonad—polycystic ovary syndrome	0.000315	0.00492	CbGeAlD
Clozapine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000315	0.00492	CbGeAlD
Clozapine—CYP1A1—vagina—polycystic ovary syndrome	0.000313	0.00489	CbGeAlD
Clozapine—Loxapine—ADRA1B—polycystic ovary syndrome	0.000311	0.0598	CrCbGaD
Clozapine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000308	0.00481	CbGeAlD
Clozapine—Quetiapine—ADRA1B—polycystic ovary syndrome	0.000303	0.0584	CrCbGaD
Clozapine—HTR2A—pituitary gland—polycystic ovary syndrome	0.000299	0.00468	CbGeAlD
Clozapine—HRH1—female gonad—polycystic ovary syndrome	0.000299	0.00467	CbGeAlD
Clozapine—HRH1—vagina—polycystic ovary syndrome	0.000297	0.00464	CbGeAlD
Clozapine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000297	0.00464	CbGeAlD
Clozapine—ABCB1—embryo—polycystic ovary syndrome	0.000296	0.00463	CbGeAlD
Clozapine—ADRA2A—female gonad—polycystic ovary syndrome	0.000293	0.00458	CbGeAlD
Clozapine—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000293	0.00457	CbGeAlD
Clozapine—ADRA2A—vagina—polycystic ovary syndrome	0.000292	0.00456	CbGeAlD
Clozapine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000282	0.0044	CbGeAlD
Clozapine—HRH1—endocrine gland—polycystic ovary syndrome	0.000278	0.00434	CbGeAlD
Clozapine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000273	0.00426	CbGeAlD
Clozapine—Amoxapine—ADRA1A—polycystic ovary syndrome	0.000268	0.0515	CrCbGaD
Clozapine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000267	0.00418	CbGeAlD
Clozapine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000267	0.00417	CbGeAlD
Clozapine—HTR2A—vagina—polycystic ovary syndrome	0.000248	0.00387	CbGeAlD
Clozapine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000243	0.00379	CbGeAlD
Clozapine—HTR2A—endocrine gland—polycystic ovary syndrome	0.000232	0.00362	CbGeAlD
Clozapine—CYP2D6—female gonad—polycystic ovary syndrome	0.000227	0.00355	CbGeAlD
Clozapine—ABCB1—endometrium—polycystic ovary syndrome	0.000217	0.00339	CbGeAlD
Clozapine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000215	0.00336	CbGeAlD
Clozapine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000211	0.0033	CbGeAlD
Clozapine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.00021	0.0405	CrCbGaD
Clozapine—Loxapine—ADRA1A—polycystic ovary syndrome	0.000209	0.0402	CrCbGaD
Clozapine—Quetiapine—ADRA1A—polycystic ovary syndrome	0.000204	0.0393	CrCbGaD
Clozapine—ABCB1—uterus—polycystic ovary syndrome	0.0002	0.00312	CbGeAlD
Clozapine—Azelastine—CYP1A1—polycystic ovary syndrome	0.0002	0.0384	CrCbGaD
Clozapine—ABCB1—pituitary gland—polycystic ovary syndrome	0.000196	0.00307	CbGeAlD
Clozapine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000195	0.00305	CbGeAlD
Clozapine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000175	0.00274	CbGeAlD
Clozapine—ABCB1—female gonad—polycystic ovary syndrome	0.000163	0.00255	CbGeAlD
Clozapine—ABCB1—vagina—polycystic ovary syndrome	0.000162	0.00254	CbGeAlD
Clozapine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000152	0.00238	CbGeAlD
Clozapine—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.94e-06	1.37e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.94e-06	1.37e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	2.91e-06	1.35e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	2.91e-06	1.35e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.91e-06	1.35e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	2.9e-06	1.35e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.89e-06	1.34e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.89e-06	1.34e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	2.88e-06	1.34e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	2.87e-06	1.33e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	2.87e-06	1.33e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.83e-06	1.32e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	2.82e-06	1.31e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.8e-06	1.3e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.79e-06	1.29e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	2.77e-06	1.29e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.77e-06	1.29e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	2.76e-06	1.28e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	2.76e-06	1.28e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	2.75e-06	1.28e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.74e-06	1.27e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.74e-06	1.27e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	2.73e-06	1.27e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.73e-06	1.27e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.73e-06	1.27e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	2.73e-06	1.27e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	2.72e-06	1.26e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.72e-06	1.26e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—INS—polycystic ovary syndrome	2.72e-06	1.26e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	2.71e-06	1.26e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	2.7e-06	1.25e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.69e-06	1.25e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.68e-06	1.25e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	2.68e-06	1.25e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	2.68e-06	1.24e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	2.68e-06	1.24e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	2.66e-06	1.23e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	2.66e-06	1.23e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	2.66e-06	1.23e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling by GPCR—IL6—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.64e-06	1.23e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	2.64e-06	1.23e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	2.64e-06	1.22e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	2.64e-06	1.22e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	2.63e-06	1.22e-05	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—IL6—polycystic ovary syndrome	2.63e-06	1.22e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	2.63e-06	1.22e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	2.63e-06	1.22e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	2.58e-06	1.2e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.58e-06	1.2e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.58e-06	1.2e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.56e-06	1.19e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	2.55e-06	1.19e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	2.55e-06	1.18e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.55e-06	1.18e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	2.54e-06	1.18e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	2.54e-06	1.18e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling by GPCR—IL6—polycystic ovary syndrome	2.54e-06	1.18e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	2.53e-06	1.17e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.52e-06	1.17e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.52e-06	1.17e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.51e-06	1.17e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	2.51e-06	1.16e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	2.5e-06	1.16e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.49e-06	1.16e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	2.49e-06	1.16e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.49e-06	1.16e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	2.48e-06	1.15e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	2.48e-06	1.15e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.45e-06	1.14e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.45e-06	1.14e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.45e-06	1.14e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	2.44e-06	1.13e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	2.44e-06	1.13e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	2.44e-06	1.13e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.44e-06	1.13e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.43e-06	1.13e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.43e-06	1.13e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.42e-06	1.13e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.42e-06	1.12e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.41e-06	1.12e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	2.4e-06	1.11e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.39e-06	1.11e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.39e-06	1.11e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.38e-06	1.11e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.38e-06	1.1e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	2.37e-06	1.1e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.36e-06	1.09e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.35e-06	1.09e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.34e-06	1.09e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	2.34e-06	1.09e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	2.34e-06	1.08e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	2.33e-06	1.08e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.33e-06	1.08e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.32e-06	1.08e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.31e-06	1.07e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.31e-06	1.07e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.3e-06	1.07e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	2.3e-06	1.07e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	2.3e-06	1.07e-05	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—IL6—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.29e-06	1.06e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.28e-06	1.06e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.28e-06	1.06e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	2.28e-06	1.06e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	2.27e-06	1.05e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.26e-06	1.05e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.26e-06	1.05e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.26e-06	1.05e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.26e-06	1.05e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.25e-06	1.05e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.25e-06	1.05e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.25e-06	1.05e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	2.25e-06	1.04e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.25e-06	1.04e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.25e-06	1.04e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	2.24e-06	1.04e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.22e-06	1.03e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.22e-06	1.03e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.22e-06	1.03e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.21e-06	1.03e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.21e-06	1.03e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.21e-06	1.02e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.2e-06	1.02e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	2.2e-06	1.02e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.2e-06	1.02e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.2e-06	1.02e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.2e-06	1.02e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.19e-06	1.02e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.18e-06	1.01e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.18e-06	1.01e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.18e-06	1.01e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—INS—polycystic ovary syndrome	2.16e-06	1e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.14e-06	9.93e-06	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.14e-06	9.91e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.11e-06	9.77e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.1e-06	9.75e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.1e-06	9.73e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.09e-06	9.72e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.09e-06	9.69e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	2.09e-06	9.68e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.07e-06	9.59e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.06e-06	9.57e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.06e-06	9.54e-06	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.05e-06	9.49e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.04e-06	9.48e-06	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.03e-06	9.44e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.03e-06	9.4e-06	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.02e-06	9.37e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.02e-06	9.36e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.02e-06	9.36e-06	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	1.99e-06	9.24e-06	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	1.98e-06	9.19e-06	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.96e-06	9.11e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.96e-06	9.09e-06	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	1.95e-06	9.06e-06	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.95e-06	9.05e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.94e-06	9.02e-06	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.92e-06	8.93e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.92e-06	8.89e-06	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	1.9e-06	8.81e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.89e-06	8.78e-06	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	1.87e-06	8.67e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.86e-06	8.62e-06	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	1.8e-06	8.36e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.78e-06	8.25e-06	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	1.78e-06	8.25e-06	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.77e-06	8.2e-06	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.76e-06	8.16e-06	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.74e-06	8.06e-06	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.73e-06	8.05e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.73e-06	8.03e-06	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.72e-06	8e-06	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.72e-06	8e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.7e-06	7.87e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.69e-06	7.85e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.69e-06	7.83e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.68e-06	7.8e-06	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.68e-06	7.78e-06	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.67e-06	7.74e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.66e-06	7.73e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.66e-06	7.71e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.66e-06	7.69e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.64e-06	7.62e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.63e-06	7.58e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.63e-06	7.54e-06	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.62e-06	7.53e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.62e-06	7.52e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.61e-06	7.48e-06	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.6e-06	7.41e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.59e-06	7.36e-06	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	1.57e-06	7.27e-06	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—IL6—polycystic ovary syndrome	1.56e-06	7.26e-06	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.55e-06	7.21e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.54e-06	7.16e-06	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.52e-06	7.06e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.51e-06	7.02e-06	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—IL6—polycystic ovary syndrome	1.5e-06	6.95e-06	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	1.48e-06	6.86e-06	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.47e-06	6.83e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.45e-06	6.72e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.45e-06	6.71e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.44e-06	6.69e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.44e-06	6.66e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.43e-06	6.65e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.42e-06	6.6e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.42e-06	6.58e-06	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	1.41e-06	6.57e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.4e-06	6.51e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.38e-06	6.43e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.38e-06	6.39e-06	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	1.35e-06	6.26e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.34e-06	6.2e-06	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	1.33e-06	6.17e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.32e-06	6.11e-06	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.2e-06	5.57e-06	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.16e-06	5.38e-06	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.15e-06	5.35e-06	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.12e-06	5.21e-06	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.1e-06	5.12e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.08e-06	5.03e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.07e-06	4.96e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.06e-06	4.93e-06	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.02e-06	4.72e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1e-06	4.65e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	9.99e-07	4.64e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	9.96e-07	4.62e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	9.93e-07	4.61e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	9.83e-07	4.56e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	9.81e-07	4.55e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	9.11e-07	4.23e-06	CbGpPWpGaD
